LONDON (AFX) - Teva Pharmaceutical Industries Ltd said it received final approval from the US Food and Drug Administration for its constipation treatment Polyethylene Glycol 3350 NF for Oral Solution.
Total annual sales of Polyethylene Glycol 3350 NF for Oral Solution are approximately 153 mln usd, Teva said. newsdesk@afxnews.com ak COPYRIGHT Copyright AFX News Limited 2005. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News. AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited